ALZAMEND NEURO Trademark

Trademark Overview

On Tuesday, September 6, 2016, a trademark application was filed for ALZAMEND NEURO with the United States Patent and Trademark Office. The USPTO has given the ALZAMEND NEURO trademark a serial number of 87161887. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2018. This trademark is owned by Alzamend Neuro, Inc.. The ALZAMEND NEURO trademark is filed in the Pharmaceutical Products category with the following description:

Synthetic peptides for the treatment of Alzheimer
alzamend neuro

General Information

Serial Number87161887
Word MarkALZAMEND NEURO
Filing DateTuesday, September 6, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Disclaimer with Predetermined Text"NUERO"
Goods and ServicesSynthetic peptides for the treatment of Alzheimer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 10, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlzamend Neuro, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101
Party NameAlzamend Neuro, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101

Trademark Events

Event DateEvent Description
Monday, February 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2017ASSIGNED TO LIE
Wednesday, March 15, 2017ASSIGNED TO LIE
Friday, March 3, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 8, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 8, 2017FINAL REFUSAL E-MAILED
Wednesday, February 8, 2017FINAL REFUSAL WRITTEN
Thursday, December 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2016ASSIGNED TO EXAMINER
Saturday, September 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 9, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuro alzamend alzheimer treatment peptides synthetic